Exponent, Inc. (EXPO)’s Stock Is Buy After Achieving All-Time High

February 25, 2018 - By Adrian Erickson

Investors sentiment decreased to 0.94 in Q3 2017. Its down 0.96, from 1.9 in 2017Q2. It dropped, as 13 investors sold Exponent, Inc. shares while 64 reduced holdings. 22 funds opened positions while 50 raised stakes. 22.66 million shares or 1.77% more from 22.27 million shares in 2017Q2 were reported.
Public Employees Retirement Association Of Colorado invested 0.14% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Los Angeles Capital & Equity Research Incorporated reported 17,117 shares or 0.01% of all its holdings. Moreover, Eulav Asset Management has 0.02% invested in Exponent, Inc. (NASDAQ:EXPO) for 5,300 shares. Hsbc Holding Public Ltd Com accumulated 6,039 shares. State Of Alaska Department Of Revenue has invested 0.02% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). First Mercantile stated it has 6,941 shares or 0.09% of all its holdings. Tompkins Finance reported 0.01% in Exponent, Inc. (NASDAQ:EXPO). Illinois-based Northern Trust Corporation has invested 0.01% in Exponent, Inc. (NASDAQ:EXPO). Blackrock, New York-based fund reported 3.16 million shares. Lord Abbett & Limited Com reported 50,000 shares stake. Texas Permanent School Fund holds 0.02% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 18,830 shares. Rice Hall James & Assocs Ltd Liability Corporation stated it has 39,718 shares. Wellington Mngmt Group Limited Liability Partnership reported 0.01% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Morgan Stanley holds 95,219 shares. Dimensional Fund Advsrs L P holds 0.03% or 926,667 shares.

Since August 25, 2017, it had 0 buys, and 8 sales for $2.03 million activity.

The stock of Exponent, Inc. (NASDAQ:EXPO) reached all time high today, Feb, 25 and still has $84.80 target or 9.00 % above today’s $77.80 share price. This indicates more upside for the $2.01B company. This technical setup was reported by Barchart.com. If the $84.80 PT is reached, the company will be worth $180.72 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 0.52% or $0.4 during the last trading session, reaching $77.8. About 55,610 shares traded. Exponent, Inc. (NASDAQ:EXPO) has risen 21.10% since February 25, 2017 and is uptrending. It has outperformed by 4.40% the S&P500.

Analysts await Exponent, Inc. (NASDAQ:EXPO) to report earnings on April, 18. They expect $0.62 EPS, up 58.97 % or $0.23 from last year’s $0.39 per share. EXPO’s profit will be $16.00 million for 31.37 P/E if the $0.62 EPS becomes a reality. After $0.47 actual EPS reported by Exponent, Inc. for the previous quarter, Wall Street now forecasts 31.91 % EPS growth.

Exponent, Inc. (NASDAQ:EXPO) Ratings Coverage

Among 2 analysts covering Exponent (NASDAQ:EXPO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Exponent had 4 analyst reports since August 26, 2016 according to SRatingsIntel. As per Friday, January 26, the company rating was upgraded by SunTrust. On Friday, August 26 the stock rating was initiated by Cantor Fitzgerald with “Buy”.

More news for Exponent, Inc. (NASDAQ:EXPO) were recently published by: Globenewswire.com, which released: “Exponent Reports Fourth Quarter and Fiscal Year 2017 Financial Results” on February 01, 2018. Globenewswire.com‘s article titled: “Exponent Increases Quarterly Dividend Payment from $0.21 to $0.26 per Share” and published on February 01, 2018 is yet another important article.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting firm worldwide. The company has market cap of $2.01 billion. The Company’s services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. It has a 50.85 P/E ratio. The firm operates in two divisions, Engineering and Other Scientific, and Environmental and Health.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: